Evidence map›Paper›PMID 42281850›Full record

ArticleWorld journal of transplantation2026

Letter to the Editor: Induction therapy as a long-term commitment: Lessons from comparative outcomes of alemtuzumab and basiliximab.

Luca Galassi, Erica Altamura, Lina Azzahrani, Federica Facchinetti, Matteo Lino Ravini

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Luca GalassiPostgraduate School of Vascular and Endovascular Surgery, University of Milan, Milan 20122, Lombardy, Italy. luca.galassi@unimi.it.
Erica AltamuraSchool of Medicine and Surgery, University of Milan, Milan 20122, Lombardy, Italy.
Lina AzzahraniSchool of Health Studies, University of Western Ontario, London N6A 3K7, Ontario, Canada.
Federica FacchinettiSchool of Medicine and Surgery, University of Milan-Bicocca, Monza 20900, Lombardy, Italy.
Matteo Lino RaviniVascular and Endovascular Unit, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milan 20157, Lombardy, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Induction immunosuppression in kidney transplantation requires a longitudinal perspective that extends beyond early rejection prevention to encompass long-term graft durability and patient safety. In response to the recent propensity score-matched study by Chukwu

Indexed as

AlemtuzumabBasiliximabGraft survivalImmunological debtInduction therapyKidney transplantationPatient safetyPrecision medicine

Identifiers

PMID42281850
PMCPMC13248072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.